Related references
Note: Only part of the references are listed.A quantitative systems pharmacology model of hyporesponsiveness to erythropoietin in rats
Ly Minh Nguyen et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants
Nayoung Kwon et al.
CURRENT OPINION IN HEMATOLOGY (2021)
Pharmacodynamic Drug-Drug Interactions
Jin Niu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Rats provide a superior model of human stress erythropoiesis
Jingxin Zhang et al.
EXPERIMENTAL HEMATOLOGY (2019)
Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease
Jiu-Hong Li et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial
Jong Wook Lee et al.
LANCET HAEMATOLOGY (2019)
A novel approach to adenine-induced chronic kidney disease associated anemia in rodents
Asadur Rahman et al.
PLOS ONE (2018)
Concise Review: Bipotent Megakaryocytic-Erythroid Progenitors: Concepts and Controversies
Juliana Xavier-Ferrucio et al.
STEM CELLS (2018)
A novel prospective isolation of murine fetal liver progenitors to study in utero hematopoietic defects
Julia E. Draper et al.
PLOS GENETICS (2018)
Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats
Ly M. Nguyen et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Molecular Signature of Megakaryocyte-Erythroid Progenitors Reveals a Role for the Cell Cycle in Fate Specification
Yi-Chien Lu et al.
CELL REPORTS (2018)
Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation
Ayako Nakamura-Ishizu et al.
CELL REPORTS (2018)
Large-Scale Ex Vivo Generation of Human Red Blood Cells from Cord Blood CD34+ Cells
Yu Zhang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Identification of unipotent megakaryocyte progenitors in human hematopoiesis
Kohta Miyawaki et al.
BLOOD (2017)
Enhanced thrombopoietin but not G-CSF receptor stimulation induces self-renewing hematopoietic stem cell divisions in vivo
Larisa V. Kovtonyuk et al.
BLOOD (2016)
Hematopoietic stem/progenitor cell commitment to the megakaryocyte lineage
Carolien M. Woolthuis et al.
BLOOD (2016)
Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell
Thalia Papayannopoulou et al.
EXPERIMENTAL HEMATOLOGY (2016)
RUNX1B Expression Is Highly Heterogeneous and Distinguishes Megakaryocytic and Erythroid Lineage Fate in Adult Mouse Hematopoiesis
Julia E. Draper et al.
PLOS GENETICS (2016)
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
Marc Michel et al.
ANNALS OF HEMATOLOGY (2015)
Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopenia
Patricia L. McElroy et al.
EXPERIMENTAL HEMATOLOGY (2015)
Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress
Amy V. Gore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
Anemia: progress in molecular mechanisms and therapies
Vijay G. Sankaran et al.
NATURE MEDICINE (2015)
Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress
Amy V. Gore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2015)
Analysis of drug combinations: current methodological landscape
Julie Foucquier et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate
Amit Grover et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects
Ingo Flamme et al.
PLOS ONE (2014)
L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats
Eylem Taskin
MEDICAL SCIENCE MONITOR (2014)
CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age
Christos Gekas et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
Derwood Pamphilon et al.
CYTOTHERAPY (2013)
Erythropoietin-Induced Erythroid Precursor Pool Depletion Causes Erythropoietin Hyporesponsiveness
Xiaoyu Yan et al.
PHARMACEUTICAL RESEARCH (2013)
Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim in Animals
Wojciech Krzyzanski et al.
PHARMACEUTICAL RESEARCH (2013)
Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575
Xiaoyu Yan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells
Michela Massollo et al.
EXPERIMENTAL HEMATOLOGY (2010)
From Stem Cell to Erythroblast: Regulation of Red Cell Production at Multiple Levels by Multiple Hormones
Harvey Lodish et al.
IUBMB LIFE (2010)
Simultaneous Pharmacokinetics/Pharmacodynamics Modeling of Recombinant Human Erythropoietin upon Multiple Intravenous Dosing in Rats
Sihem Ait-Oudhia et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Current status of thrombopoietic agents
Elizabeth Rhodes et al.
EXPERT REVIEW OF HEMATOLOGY (2010)
Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody (TM) Construct CNTO 528 in Healthy Subjects
Juan Jose Perez-Ruixo et al.
CLINICAL PHARMACOKINETICS (2009)
Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients
Elisio Costa et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects
Juan Jose Perez-Ruixo et al.
CLINICAL PHARMACOKINETICS (2008)
Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34(+) cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis
Sandra G. Olthof et al.
STEM CELLS (2008)
Assessment of basic indirect pharmacodynamic response models with physiological limits
ZL Yao et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Expression and function of NJ-1 surface antigen in megakaryopoiesis
H Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia
M Piron et al.
BLOOD (2001)
Identification of an erythroid active element in the transferrin receptor gene
CN Lok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
